IDMC-6 - The Sixth International Myotonic Dystrophy Consortium Meeting

Published: 10 August 2009
Abstract Views: 507
PDF: 468
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

In 1992 three groups of investigators found that myotonic dystrophy of Steinert, classical myotonic dystrophy, now known as myotonic dystrophy type 1 (DM1), results from an unstable CTG repeat expansion in the non-coding 3’ region of serinethreonine kinase gene DMPK at 19q13.3. Almost a decade later in 2001 collaborators in Minnesota and Germany discovered a second gene defect responsible for myotonic dystrophy type 2 (DM2), another autosomal dominant, multisystem disease, that is similar to but distinct from DM1. DM2 results from an unstable CCTG repeat expansion in intron 1 of the zinc finger protein 9 gene ZNF9 at 3q21. The exact cause for the instability of the DNA at these two different loci, and the explanation for the tissue mosaicism that exists in different tissues in DM1 and DM2 remains a mystery although part of the answer probably lies in faulty repair of DNA. Why the CTG repeat expansion in DM1 is larger in skeletal and cardiac muscle and in certain parts of the brain than in circulating leucocytes and some other tissues is not clear. Whether this tissue mosaicism accounts for or plays a major role in determining the spectrum of disease manifestations requires further investigation.Whether it is possible to use the tissue instability of DNA in refining the diagnosis and prognosis of patients with DM1 and DM2 is a question that has yet to be explored.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Meola, G. (2009). IDMC-6 - The Sixth International Myotonic Dystrophy Consortium Meeting. European Journal of Histochemistry, 51(4), 311–313. https://doi.org/10.4081/1157